Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
46 | 3 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 102919 |
49 | 2 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 30279 |
9391 | 1 | ENFUVIRTIDE//FUSION INHIBITOR//GP41 | 1192 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ENFUVIRTIDE | authKW | 1671231 | 8% | 69% | 91 |
2 | FUSION INHIBITOR | authKW | 1608502 | 9% | 60% | 102 |
3 | GP41 | authKW | 1486192 | 11% | 41% | 136 |
4 | T 20 | authKW | 719781 | 3% | 83% | 33 |
5 | LINDSLEY F KIMBALL | address | 394108 | 8% | 16% | 96 |
6 | HIV FUSION INHIBITOR | authKW | 376098 | 2% | 68% | 21 |
7 | SIX HELIX BUNDLE | authKW | 365593 | 2% | 63% | 22 |
8 | HIV 1 FUSION INHIBITOR | authKW | 319151 | 1% | 93% | 13 |
9 | ENTRY INHIBITOR | authKW | 234948 | 3% | 22% | 40 |
10 | HIV ENTRY INHIBITOR | authKW | 178457 | 1% | 75% | 9 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Virology | 14162 | 26% | 0% | 313 |
2 | Infectious Diseases | 2857 | 15% | 0% | 180 |
3 | Chemistry, Medicinal | 2196 | 13% | 0% | 158 |
4 | Biochemistry & Molecular Biology | 1482 | 32% | 0% | 376 |
5 | Pharmacology & Pharmacy | 874 | 18% | 0% | 212 |
6 | Immunology | 549 | 12% | 0% | 141 |
7 | Biophysics | 384 | 7% | 0% | 89 |
8 | Microbiology | 356 | 9% | 0% | 102 |
9 | Chemistry, Organic | 261 | 8% | 0% | 98 |
10 | Biochemical Research Methods | 52 | 3% | 0% | 38 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | LINDSLEY F KIMBALL | 394108 | 8% | 16% | 96 |
2 | LINDSEY F KIMBALL | 158632 | 1% | 100% | 6 |
3 | EDASA SCI | 105755 | 0% | 100% | 4 |
4 | TROP DIS CONTROL MOE | 79316 | 0% | 100% | 3 |
5 | MOL MODELING DRUG DESIGN | 67966 | 1% | 21% | 12 |
6 | BIOMODULATORS DRUGS | 52877 | 0% | 100% | 2 |
7 | CHEM DEV CHEM DEV OPERAT | 52877 | 0% | 100% | 2 |
8 | HUMAN VIROLMINIST EDUC | 52877 | 0% | 100% | 2 |
9 | UAB HIV OUTPATIENT CLIN | 52877 | 0% | 100% | 2 |
10 | VIRUS CONTROL | 45039 | 1% | 15% | 11 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF VIROLOGY | 6757 | 9% | 0% | 102 |
2 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 6576 | 3% | 1% | 37 |
3 | RETROVIROLOGY | 4151 | 1% | 1% | 14 |
4 | HIV CLINICAL TRIALS | 3207 | 1% | 2% | 8 |
5 | AIDS | 3035 | 3% | 0% | 32 |
6 | CHEMMEDCHEM | 1827 | 1% | 1% | 13 |
7 | ANTIVIRAL THERAPY | 1637 | 1% | 1% | 11 |
8 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1431 | 3% | 0% | 37 |
9 | JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE | 1364 | 1% | 1% | 6 |
10 | CURRENT PHARMACEUTICAL DESIGN | 1301 | 2% | 0% | 18 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ENFUVIRTIDE | 1671231 | 8% | 69% | 91 | Search ENFUVIRTIDE | Search ENFUVIRTIDE |
2 | FUSION INHIBITOR | 1608502 | 9% | 60% | 102 | Search FUSION+INHIBITOR | Search FUSION+INHIBITOR |
3 | GP41 | 1486192 | 11% | 41% | 136 | Search GP41 | Search GP41 |
4 | T 20 | 719781 | 3% | 83% | 33 | Search T+20 | Search T+20 |
5 | HIV FUSION INHIBITOR | 376098 | 2% | 68% | 21 | Search HIV+FUSION+INHIBITOR | Search HIV+FUSION+INHIBITOR |
6 | SIX HELIX BUNDLE | 365593 | 2% | 63% | 22 | Search SIX+HELIX+BUNDLE | Search SIX+HELIX+BUNDLE |
7 | HIV 1 FUSION INHIBITOR | 319151 | 1% | 93% | 13 | Search HIV+1+FUSION+INHIBITOR | Search HIV+1+FUSION+INHIBITOR |
8 | ENTRY INHIBITOR | 234948 | 3% | 22% | 40 | Search ENTRY+INHIBITOR | Search ENTRY+INHIBITOR |
9 | HIV ENTRY INHIBITOR | 178457 | 1% | 75% | 9 | Search HIV+ENTRY+INHIBITOR | Search HIV+ENTRY+INHIBITOR |
10 | T20 | 159944 | 1% | 55% | 11 | Search T20 | Search T20 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |